Alira Health, international healthcare and life sciences advisory firm, announced that it has acquired Clinical Insights, a data science organization providing data analytics and predictive analysis to healthcare companies. The acquisition will add rich data to each of Alira Health’s practice areas, including innovation, regulatory, clinical, strategy, and transaction advisory services.
Founded in 2012, Milano, Italy-based Clinical Insights provides tools and business advisory services based on rich data analytics for pharmaceutical companies. Its solutions optimize performance using dynamic analytical techniques based on real-world and real-time market information; improves market insights and develop business solutions based on sophisticated analyses of big data available in real time; and improves business performance by embedding analytical techniques and real-time proprietary market information into the user’s management systems.
Alira Health’s services encompass innovation, regulatory, clinical, strategic, and transaction advisory services, touching nearly every aspect of healthcare, including Pharmaceuticals, MedTech, Biotech, Healthcare Services and IT. Post-acquisition, the collective organization will now support its clients with a host of complementary, integrated services, including helping clients address the challenges in implementing new value-based care models in the U.S. and EU, as well as clinical trial cost and recruitment, reimbursement, health economics, market access, and the development of tailored data products.
“We have been actively looking for the right analytics platform to complement our organization and provide our practice areas with additional data tools to give clients deeper insights and recommendations backed by science,” said Gabriele Brambilla, CEO of Alira Health. “We are thrilled to welcome Clinical Insights and their amazing team to Alira Health. The addition of their data analytics capabilities is key to supporting strategic, commercial, regulatory, clinical, and innovation decision making processes in new healthcare ecosystems. We are excited to add this new competence and deliver the best value to our clients.”
Financial details of the acquisition were not disclosed.
